Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Koehler

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 22, 2019
Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literatureDanila Seidel, Angela Hassler, Jon Salmanton-García, et al.
Journal of Clinical Microbiology|March 24, 2022
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a <i>Post Hoc</i> Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis StudyDaniele Roberto Giacobbe, Juergen Prattes, Joost Wauters, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
Genomic and phenotypic analysis of COVID-19-associated pulmonary aspergillosis isolates of <i>Aspergillus fumigatus</i>Jacob L Steenwyk, Matthew E Mead, Patrícia Alves de Castro, et al.
Microbiology Spectrum|June 9, 2021
Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatusJacob L Steenwyk, Matthew E Mead, Patrícia Alves de Castro, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of actionMartin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
Chest|April 19, 2026
Effects of antifungal treatment in COVID-19-associated pulmonary aspergillosis: A European multicenter cohort studyFlorian Reizine, Simon Feys, Danila Seidel, et al.
The Journal of Infectious Diseases|March 4, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic MarkersAna Pereira, Jennifer Scott, Andrei Sarlea, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 12, 2025
Sequential serum galactomannan as outcome marker for invasive aspergillosis-An exploratory study from the FungiScope registryChristina Többen, Oliver A Cornely, Carolin S Joisten, et al.
Mycoses|March 18, 2020
European confederation of medical mycology expert consult-An ECMM excellence center initiativePhilipp Koehler, Blandine Denis, David W Denning, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 22, 2019
Invasive Scedosporium spp. and Lomentospora prolificans infections in pediatric patients: Analysis of 55 cases from FungiScope® and the literatureDanila Seidel, Angela Hassler, Jon Salmanton-García, et al.
Journal of Clinical Microbiology|March 24, 2022
Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a <i>Post Hoc</i> Analysis from the European Confederation of Medical Mycology (ECMM) COVID-19-Associated Pulmonary Aspergillosis StudyDaniele Roberto Giacobbe, Juergen Prattes, Joost Wauters, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
Genomic and phenotypic analysis of COVID-19-associated pulmonary aspergillosis isolates of <i>Aspergillus fumigatus</i>Jacob L Steenwyk, Matthew E Mead, Patrícia Alves de Castro, et al.
Microbiology Spectrum|June 9, 2021
Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatusJacob L Steenwyk, Matthew E Mead, Patrícia Alves de Castro, et al.
Expert Opinion on Investigational Drugs|June 3, 2022
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of actionMartin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
Chest|April 19, 2026
Effects of antifungal treatment in COVID-19-associated pulmonary aspergillosis: A European multicenter cohort studyFlorian Reizine, Simon Feys, Danila Seidel, et al.
The Journal of Infectious Diseases|March 4, 2026
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic MarkersAna Pereira, Jennifer Scott, Andrei Sarlea, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)Jannik Stemler, Sibylle C Mellinghoff, Yascha Khodamoradi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 12, 2025
Sequential serum galactomannan as outcome marker for invasive aspergillosis-An exploratory study from the FungiScope registryChristina Többen, Oliver A Cornely, Carolin S Joisten, et al.
Mycoses|March 18, 2020
European confederation of medical mycology expert consult-An ECMM excellence center initiativePhilipp Koehler, Blandine Denis, David W Denning, et al.
Pageof 13